Document:

Exhibit 10.11     Douglas K. Beplate - Assignment of Technology Agreement 4/1/03

                                LICENSE AGREEMENT

                  This License Agreement, hereinafter termed the "Agreement," is
made to be effective as of the 1st day of April, 2003, by and between Douglas K.
Beplate, hereinafter termed the "Licensor," who is an individual resident of
Nevada, with an address of 2254 Candlestick Avenue, Henderson, Nevada 89052, and
Emergency Filtration Products, Inc., hereinafter termed the "Licensee," which is
a Nevada corporation with its principal place of business located at 175 Cassia
Way, Suite A115, Henderson, Nevada 89014.

                             GENERAL CONSIDERATIONS
                             ----------------------

         A. Licensor is the Licensor and owner of certain discoveries and
inventions relating to filtering devices incorporating Nanoparticles described
in United States patent application no. 10/387,854 and of knowledge, processes,
technology, data and trade secrets associated with such discoveries and
inventions.

         B. Licensee desires to utilize the discoveries and inventions of the
patent application and the knowledge, processes, technology, data, and trade
secrets associated with the patent application to make, use, sell, and offer to
sell military equipment and environment face masks.

                                      TERMS
                                      -----

         NOW, THEREFORE, in consideration of the above premises and the mutual
covenants and promises hereinafter contained, Licensor and Licensee agree as
follows:

                                    Article I

                                   Definitions

         1.01 Licensed Technology. The term "Licensed Technology" means the
discoveries and inventions of the patent application and the knowledge,
processes, technology, data, and trade secrets associated with described in
United States patent application no. 10/387,854 and of knowledge, processes,
technology, data, and trade secrets associated with discoveries and inventions.

         1.02 Gross Sales Proceeds. The term "Gross Sales Proceeds" means all
compensations received by Licensee for the sale or other transfer of any product
manufactured by using the Licensed Technology or any improved version of the
Licensed Technology. If, however, any sale or other transfer is made for less
than fair market value, the gross sales proceeds of such sale or transfer shall
be deemed to be the fair market value of the product sold or transferred.

                                   Article II

                                Grant of License

         2.01 License. Licensor hereby grants to Licensee an exclusive worldwide
license to utilize the Licensed Technology as it exists on the effective date of
this Agreement, or as it may be improved during the term of this Agreement, to
manufacture military equipment and environment face masks.

                                   Article III

                              Royalties and Reports
<PAGE>

         3.01 Value of Licensed Technology. Licensee recognizes that the
Licensed Technology has value independent of whether a patent is granted and
that the value of the Licensed Technology independent of a patent is
approximately half of what it would be with a patent.

         3.02  Earned Royalty. Licensee  shall  pay to  Licensor  a  royalty  of
one  percent  of Gross  Sales Proceeds.

         3.03 Reduction of Royalty. At such time as the last patent on the
Licensed Technology expires or as it is conclusively determined that no patent
will issue on the Licensed Technology (all appeals concerning existing patent
application have been exhausted without a patent being granted and no further
patent applications can be filed on the Licensed Technology in the United States
or elsewhere), whichever occurs later, the royalty specified in paragraph 3.02
shall be reduced to one-half percent of the Gross Sales Proceeds. Licensee
shall, however, be entitled to no refund of royalties due payable prior to such
time.

         3.04 Time for Royalty Payments.Royalty payments due under this
Agreement shall be computed for each calendar quarter and paid, together with a
written accounting explaining how such quarterly payment has been calculated,
within thirty days after the end of each calendar quarter.

         3.05 Interest. Licensee shall pay to Licensor interest, at the legal
rate in the State of Nevada, for any royalty payment that is overdue. Such
interest shall apply from the time the royalty payment is due until the date
such royalty is actually paid.

         3.06 Records. Licensee shall keep correct and complete records with
respect to sales and sublicenses involving the "Piccolo" invention.

         3.07 Inspection of Records. Such records of Licensee shall be open to
inspection at all reasonable time during normal business hours by a
representative of Licensor acceptable to Licensor and Licensee or, at the
request either of Licensor or of Licensee, by an independent certified public
accountant acceptable to Licensor and Licensee. Licensor shall provide to
Licensee written notice of any desired inspection at least fifteen (15) calendar
days in advance of the date for such inspection. The entity requesting that an
inspection be performed by an independent certified public accountant shall be
fully responsible to pay such accountant. The representative or accountant shall
report to Licensor only such information as is required to compute the royalty
payments due pursuant to this Agreement. No more than one (1) inspection shall
be permitted each calendar year unless Licensor demonstrates reasonable grounds
for believing that a royalty payment has not been accurately determined. Every
inspection shall be limited to those records which Licensee is required to
maintain pursuant to this Agreement and shall not include any records which are
more than six (6) years old at the time of inspection. Except as necessary
judicially to resolve any bona fide dispute concerning royalty payments.
Licensor agrees to maintain all information received from any inspection
confidential and to impose a similar requirement of confidentiality upon any
accountant who conducts an inspection in accordance with this paragraph.
                                   Article IV

                                     Patents

         4.01 Patent Prosecution. Licensor  has  sought  patent  protection  as
a utility  patent for the Licensed Technology in the United States.

         4.02 Appeals. Licensor shall appeal administratively any final
rejection if any attorney licensed to practice before the United States Patent
and Trademark Office provides an opinion that such an appeal would have a
reasonable likelihood of success at a reasonable cost.

         4.03 Election Not to Appeal. If Licensor does not appeal a final
rejection by the United States Patent and Trademark Office, Licensee may pursue
such an appeal at Licensee's own cost.

         4.04 Patenting outside the United States. The seeking of patents
outside the United States may be done in the discretion of Licensor. If, though,
Recipient elects not to prosecute a patent application in a country where
Licensee has traditionally done business, Licensor shall notify Licensee of such
election within such period of time as to enable Licensee to seek such patent
protection at Licensee's own cost.
<PAGE>

                                    Article V

                             Assistance by Licensor

         5.01 Cooperation. Licensor will provide to Licensee all information and
assistance reasonably necessary for the patenting by Licensee of the Licensed
Technology pursuant to Article IV of this Agreement.

                                   Article VI

                                   Warranties

         6.01 Ownership. Licensor represents and warrants that Licensor holds
title to and is the exclusive owner of all rights in the Licensed Technology.

         6.02 Authority. Licensor represents and warrants that Licensor has the
authority to grant the license which is the subject of this Agreement and that
no assignment, sale, agreement, or encumbrance has been, or will be, made or
entered which would conflict with or be prior in right to such license.

         6.03 Patent Infringement. Licensor provides to Licensee no warranty of
non-infringement of any patent. Licensor will, consequently, not be liable to
defend Licensee in any suit for infringement or to reimburse Licensee for any
sums expended in defending, or satisfying a judgment resulting from, a charge of
patent infringement.
                                   Article VII

                 Patent Infringement of the Licensed Technology

         7.01 Notification. Once a patent has been obtained for the Licensed
Technology, Licensor and Licensee shall promptly notify one another of any
apparent infringement by a third party of such patent.

         7.02 Suit for Infringement. Licensor shall not be obligated to
institute a lawsuit against any apparent infringer. If, however, Licensor
commences such a lawsuit, Licensor shall be solely responsible for the expenses
of such lawsuit and shall retain all proceeds form such lawsuit.

         7.03 Suit by License. Despite the provisions of paragraph 7.02 of this
Agreement, if any apparent infringement involves a product that is primarily in
the field of military equipment or environmental face masks, Licensor shall,
before instituting any lawsuit, provide Licensee the opportunity to institute
such lawsuit, in Licensor's name but at Licensee's cost. If Licensee commences
such a lawsuit, Licensor, upon Licensee's request and at Licensee's expense,
shall provide all reasonable assistance with respect to such lawsuit, including
making Licensor's employees and agents available to testify on Licensee's
behalf. Unless Licensor and Licensee otherwise agree, License shall, as
indicated above, be solely responsible for the expenses of such litigation and
with any recovery obtained therefrom shall first be fully reimbursed for such
expenses. Ninety-Nine (99) percent of the remainder of any such recovery shall
belong to Licensee; and one (1) percent, to Licensor.

         7.04 Unavailability of Recourse. If Licensor or Licensee shall be
unable to uphold the validity of any patent for the Licensed Technology against
an alleged infringer, Licensee shall have no damage claim and no claim for
refund or reimbursement against Licensor.

                                  Article VIII

                           Termination of Exclusivity
<PAGE>

         8.01 Automatic Conversion. Whenever no royalties shall have been due
for a continuous period of three years pursuant to Article III of this
Agreement, the license granted pursuant to Article II of this Agreement shall
automatically convert to a non-exclusive license.

                                   Article IX

                                 Confidentiality

         9.01 Obligation of Confidentiality. Licensor and Licensee agree that
each will take all reasonable and necessary steps to protect the confidentiality
of any and all trade secrets included in the Licensed Technology.
                                    Article X

                                    Insurance

         10.01 Product Liability. Licensee agrees to obtain such product
liability insurance for products incorporating the Licensed Technology as is
commercially reasonable under the circumstances and to include Licensor as a
named insured under any such policy of product liability insurance.

         10.02 Indemnification. Licensee shall indemnify and hold Licensor
harmless for any recovery and any reasonable attorney's fees associated with any
claim of product liability for a product based upon the Licensed Technology.

                                   Article XI

                            Miscellaneous Provisions

         11.01 Marketing. Licensee agrees to use reasonable efforts to place
appropriate legal patent markings on every product incorporating the Licensed
Technology produced after issuance of any patent for the Licensed Technology.

         11.02 Force Majeur. Except for the obligation to make payments when due
pursuant to this Agreement, all other obligations under this Agreement shall be
suspended for so long as one or both of Licensor and Licensee is prevented from
complying with the provisions of this Agreement by acts of God; riots; war; acts
of Federal, state, or local governments, agencies, or courts; strikes;
lock-outs; damage to or destruction or unavoidable shut-down of necessary
facilities; or other matters beyond Licensor's or Licensee's reasonable control
(specifically excluding, however, matters of mere financial exigency.) The
entity so prevented from complying with its obligations pursuant to this
Agreement shall promptly notify the other entity of such fact and shall exercise
all due diligence to remove and overcome the cause of such inability to comply.

         11.03 Additional Documents. Licensor and Licensee agree that they will
execute any and all additional documents or legal instruments that may be
necessary or required to effectuate the provisions of this Agreement.

         11.04 Remedies. Notwithstanding any other provisions of this Agreement,
Licensor and Licensee shall retain all statutory and common law rights to
enforce this Agreement or to seek damages for its breach.

         11.05 Notices. Any notice, election, payment, report, or other
correspondence required or permitted pursuant to this Agreement shall be deemed
to have been properly given or delivered when it has been made in writing and

         (a) delivered personally to Licensor or an officer of Licensee or

         (b) when sent by United States mail with all necessary postage fully
prepaid, a return receipt requested, and addressed to the entity to whom
directed at its address as specified below:
<PAGE>

    Emergency Filtration Products, Inc.         Douglas K. Beplate
    175 Cassia Way, Suite A115                  2245 Candlestick Avenue
    Henderson, NV  89014                        Henderson, NV  89052

         Either Licensor or Licensee may, at any time, change its address for
purposes of this Agreement by giving written notice of such change of address to
the other entity.

         11.06 Assignment. This Agreement was entered, in part, based upon
Licensor's unique knowledge of the Licensed Technology. Accordingly, Licensor
shall not assign or otherwise transfer Licensor's duties or rights (other than
the right to receive the royalty pursuant to Article III, which right shall be
freely transferable) without the prior written consent of Licensee, which
consent shall not be unreasonably withheld. Assignee may assign its rights and
delegates its duties under this Agreement.

         11.07 Third-party Beneficiaries.Nothing expressed in or implied from
this Agreement is intended, or shall be construed, to confer upon or give any
entity, other than Licensor and Licensee, and their respective successors and
assigns, any rights or remedies under or by reason of this Agreement.

         11.08 Effect of Waiver. A waiver either by Licensor or by Licensee of
any provisions of this Agreement, whether in writing or by course of conduct or
otherwise, shall be valid only in the instance for which such waiver has been
given and shall not be deemed to be a continuing waiver of such provision; nor
shall any such waiver be construed to be a waiver of any other provisions of
this Agreement.

         11.09 Paragraph Headings. The paragraph headings within this Agreement
are for convenience only and in no way define, limit, or describe the scope or
intent of this Agreement; nor do such paragraph headings affect the terms and
provisions of this Agreement.

         11.10 Preparation of Agreement. Licensor and Licensee acknowledge that
they have both participated in the preparation of this Agreement; and, in the
event that any question arises regarding the interpretation of this Agreement,
no presumption shall be drawn in favor of or against either Licensor or Licensee
with respect to the meaning of this Agreement.

         11.11 Governing Law. This agreement, and all matters relating to this
Agreement, including any matter or dispute arising from this Agreement, shall be
interpreted, governed, and enforced according to the laws of the State of
Nevada. Developer and Recipient consent to the jurisdiction and venue of any
appropriate court within the State of Nevada to resolve any such dispute.

         11.12 Attorney's Fees. In the event that Licensor or Licensee shall be
in default or breach of this Agreement, such defaulting or breaching entity
shall be liable to pay all reasonable attorney's fees, court costs, and other
related collection costs and expenses incurred by the non-defaulting or
non-breaching entity in pursuing its rights under this Agreement.

         11.13 Severability. In the event that any provision of this Agreement,
or any action contemplated pursuant to this Agreement, is found, by a court
having competent jurisdiction in accordance with this Agreement, to be
inconsistent with or contrary to any law, ordinance, or regulation, the latter
shall be deemed to control; this Agreement shall be regarded as modified
accordingly; as such modified provision as well as the remainder of this
Agreement shall continue in full force and effect.

         11.14 Integration. This Agreement constitutes and represents the entire
agreement of Licensor and Licensee with respect to the subject matter of this
Agreement. All other prior agreements, covenants, promises, and conditions,
whether verbal or written, that are intended to apply between Licensor and
Licensee have been incorporated herein. In executing this Agreement, neither
Licensor nor Licensee has relied upon any promise, representation, warranty, or
the like other than those contained within this Agreement.

         11.15 Amendment. This Agreement may be amended at any time upon the
unanimous agreement of Licensor and Licensee. Any such amendment must, however,
be reduced to writing and be executed both by Licensor and by Licensee in order
to become effective.
<PAGE>

         11.16 Assurance of Authority. Licensor does hereby assure Licensee that
execution of this Agreement is an authorized act of Licensor, and Licensee does
hereby assure Licensor that execution of this Agreement is an authorized act of
Licensee.

         11.17 Binding Effect. This Agreement shall be binding upon and inure to
the benefit of Licensor and Licensee as well as their successors and assigns.

         11.18 Counterparts. This Agreement may be executed in counterparts,
each of which when so executed and delivered (including by facsimile
transmission) shall be deemed an original and all of which together shall
constitute one and the same instrument.

         IN WITNESS WHEREOF, Licensor and Licensee have caused these presents to
be signed by their duly authorized representatives on the dates indicated.

                             LICENSOR:

                             DOUGLAS K. BEPLATE

                             __\s\Douglas K. Beplate______________________

                                      Date:  _April 1, 2003__________________

                             RECIPIENT:

                             EMERGENCY FILTRATION PRODUCTS, INC.

                             By __\s\Sherman Lazrus____________________

                                      Its _C.E.O.________________________

                                      Date:  _April 1, 2003________________

                             By __\s\Thomas Glenndahl__________________

                                      Its _Director________________________

                                      Date:  _April 1, 2003_________________

                             ASSIGNMENT OF INVENTION

         Douglas K. Beplate, an individual resident of Nevada, with an address
of 2254 Candlestick Avenue, Henderson, Nevada 89052 (hereinafter termed
"ASSIGNOR") does hereby acknowledge receipt of good and valuable consideration
from Emergency Filtration Products, Inc., a Nevada corporation, with an address
of 175 Cassia Way, Suite A115, Henderson, Nevada 89014 (hereinafter termed
"ASSIGNEE").
<PAGE>

         In exchange for such consideration, ASSIGNOR does hereby sell, assign,
and transfer to ASSIGNEE his entire right, title, and interest for the United
States and its territorial possessions and for all foreign countries, including
all rights to claim priority, in and to any and all inventions that are
disclosed in United States patent no. 5,575,279, Australian patent no. 723311,
French patent no. 96945105.3, German patent no. 69610644, United Kingdom patent
no. 0873151, Canadian patent application no. 2,246,770, United States patent no.
6,375,854, and United States patent application serial no. 10/128,367; in and to
such patents and patent applications; in and to any other provisional or
non-provisional application that claims priority to any of such patents or
patent applications; in and to any patent that issues on an invention disclosed
in any of the patent application; and in and to any reissue, re-examination, or
extension thereof and any related statutorily provided periods of market
exclusivity.

         ASSIGNOR hereby represents and warrants that ASSIGNOR has the full
right to convey his entire right, title, and interest herein assigned and that
no assignment, sale, agreement, or encumbrance has been, or will be, made or
entered which would conflict with or be prior in right to this Assignment.

         ASSIGNOR further covenants that ASSIGNEE will, upon its request, be
promptly provided with all pertinent facts and documents relating to said
inventions, said patent applications, and said patents and legal equivalents as
may be known and accessible to ASSIGNOR and that ASSIGNOR will testify as to the
same in any interference, litigation, or other proceeding related thereto and
will promptly execute and deliver to ASSIGNEE or its legal representatives any
and all papers, instruments, or affidavits required to apply for, obtain,
maintain, issue, and enforce said invention and said patents and said
equivalents thereof which may be necessary or desirable to accomplish the
purposes thereof or of this Assignment.

         IN WITNESS WHEREOF, I have hereunto set hand and seal as of the dates
specified below.

                                        ASSIGNOR:

                                        Douglas K. Beplate

                                        _\s\Douglas K. Beplate____________

                                        Date:  _April 1, 2003_____________Exhibit 10.12     Term Sheet Joseph Stevens & Co. 1/31/03

                   Proposed Term Sheet (Strictly Confidential)

Issuer:                    Emergency Filtration Products  (OTC BB: EMFP)

Amount of Placement:       A minimum of $300,000 and a maximum of $600,000.

Securities:                Authorized but unregistered common stock priced at
                           $.18 per share plus one three year, non callable
                           warrant for every dollar invested exercisable at
                           $0.25. The warrant will be registered with the above
                           issued common stock.

Closing Date:              On or about March 1, 2003.

Registration:              Promptly, but no later than thirty (30) days from the
                           closing date, the Issuer shall file a registration
                           statement with the United States Securities &
                           Exchange Commission ("SEC") and use its best efforts
                           to ensure that such registration statement is
                           declared effective within 90 days from the filing
                           date. In the event the registration statement is not
                           declared effective within 90 days, the Issuer's
                           registration obligation is deemed in default. As a
                           result, the Issuer shall pay to the Investor(s) a
                           cash amount, within 3 business days for every 30 day
                           period starting from the 91st day from closing until
                           such default is cured, equal to 2% of the outstanding
                           principal amount of investment per month, as
                           liquidated damages, and not as penalty. The Issuer
                           shall keep the registration statement "evergreen" for
                           at least 2 years from the anniversary date from the
                           closing.

Placement Fees:            Issuer agrees to pay placement agent a
                           placement fee of 10% plus a non accountable charge of
                           3% of the gross proceeds raised payable in cash
                           directly from escrow. Furthermore, for every dollar
                           of the gross proceeds raised Joseph Stevens & Co.
                           will receive one 3 year non callable warrant
                           exercisable at $0.25.

No Undercut:               Within 180 days from the date that the
                           investor(s) may legally sell the stock in the open
                           market, if Issuer issues additional common stock or
                           convertible instrument with the potential for the
                           common stock priced below the average closing price
                           of this placement, additional shares to make up the
                           difference shall be automatically issued to
                           investor(s) at no further cost to investor(s).

     Look Back Clause: Upon the completion of the registration, the average of
the bid and ask prices for the prior 3 days of trading must be at or above $.18.
If the average is below that price, additional shares to make up the difference
shall be automatically issued to investor(s) at no further cost to investor(s).
Starting 120 days from the date of effective registration, if any average ten
trading days' closing bid is below $0.18, then Issuer agrees to issue additional
common stock at Market Price (defined as the average of ten trading days'
closing bid price prior to the date of written request from investor) to make up
the difference between the investor's total net exit price and 120% of the
original investment. (Open book with respect to all transaction records of
Issuer's common stock is permitted for inspection by Issuer or its
representative). In lieu of issuing such additional stock, Issuer has the option
to redeem said financial damage, i.e. 120% of original investment - total net
sales proceeds, in cash.

Date: January 31, 2003
     -----------------

Signed  \s\Douglas K. Beplate
       ------------------------

Name in Print  Douglas K. Beplate
             ---------------------

Position: President, Emergency Filtration Products
         -----------------------------------------

 Date: January 29, 2003
       -----------------

 Signed:  \s\Joseph Sabora
        --------------------

 Name in Print  Joseph Sabora
              ----------------

     Position:  CEO, Joseph Stevens & Co.
              --------------------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}]]